Heyman Enerio Gattuso & Hirzel LLP

Delaware

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases353

Challenger50%

Patent Owner50%

NPE50%

Practice Areas

BiotechComp. Arch. and SoftwareCommunications

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
09/17/24	Astellas Pharma Inc v. Sandoz Inc 1:20-CV-01589 ( D. DE )	Pro Hac Vice Fee - Credit Card Payment received for Diva Hollis. ( re [618] MOTION for Pro Hac Vice Appearance of Attorney Diva Hollis )( Payment of $ 50, receipt number ADEDC-4500269).(Silver, Daniel) (Entered: 09/17/2024)
09/17/24	Astellas Pharma Inc v. Sandoz Inc 1:20-CV-01589 ( D. DE )	MOTION for Pro Hac Vice Appearance of Attorney Diva Hollis - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # [1] Certification of Diva Hollis)Motions referred to Christopher J. Burke.(Silver, Daniel) (Entered: 09/17/2024)
09/16/24	Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc 1:22-CV-01395 ( D. DE )	REDACTED VERSION of [287] Letter, by Gerbera Therapeutics Inc., Nanjing Noratech Pharmaceutical Co., Limited. (Attachments: # [1] Exhibit G, # [2] Exhibit H, # [3] Exhibit I)(Gattuso, Dominick) (Entered: 09/16/2024)
09/16/24	Abbvie Inc v. Alkem Laboratories Ltd 1:22-CV-01423 ( D. DE )	SO ORDERED, re [273] Stipulation and Order to Extend Expert Reports and Daubert Motions Deadlines. (Reset Scheduling Order Deadlines: Opening Expert Reports due by 11/14/2024; Rebuttal Expert Reports due by 1/23/2025; Reply Expert Reports due by 2/14/2025; Close of Expert Discovery on 4/10/2025; Daubert Motions due by 4/17/2025). Signed by Judge Jennifer L. Hall on 9/16/2024. (ceg) (Entered: 09/16/2024) SO ORDERED, re [273] Stipulation and Order to Extend Expert Reports and Daubert Motions Deadlines. (Reset Scheduling Order Deadlines: Opening Expert Reports due by 11/14/2024; Rebuttal Expert Reports due by 1/23/2025; Reply Expert Reports due by 2/14/2025; Close of Expert Discovery on 4/10/2025; Daubert Motions due by 4/17/2025). Signed by Judge Jennifer L. Hall on 9/16/2024. (ceg) (Entered: 09/16/2024)
09/16/24	In re: Entresto (Sacubitril/Valsartan) Patent Litigation 1:20-MD-02930 ( D. DE )	REDACTED VERSION of [1528] Letter, by Gerbera Therapeutics Inc., Nanjing Noratech Pharmaceutical Co., Limited. (Attachments: # [1] Exhibit G, # [2] Exhibit H, # [3] Exhibit I)(Gattuso, Dominick) (Entered: 09/16/2024)
09/16/24	In re: Xarelto (Rivaroxaban) ('310) Patent Litigation 1:21-MD-03017 ( D. DE )	REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # [297] . (nms) (Entered: 09/16/2024)
09/16/24	In re: Entresto (Sacubitril/Valsartan) Patent Litigation 1:20-MD-02930 ( D. DE )	DEFICIENCY NOTICE by the Court issued to Gerbera Therapeutics, Inc. and Nanjing Noratech Pharmaceutical Co. Limited re [1539] Redacted Document. Upon review it was determined this filing was not a complete version of what was filed at D.I. [1528] . The redaction lacked Exhibit I. Defendants are to file a revised redacted version of D.I. [1528] no later than three (3) days from the date of this notice. (nms) (Entered: 09/16/2024) DEFICIENCY NOTICE by the Court issued to Gerbera Therapeutics, Inc. and Nanjing Noratech Pharmaceutical Co. Limited re [1539] Redacted Document. Upon review it was determined this filing was not a complete version of what was filed at D.I. [1528] . The redaction lacked Exhibit I. Defendants are to file a revised redacted version of D.I. [1528] no later than three (3) days from the date of this notice. (nms) (Entered: 09/16/2024)
09/16/24	Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc 1:22-CV-01395 ( D. DE )	DEFICIENCY NOTICE by the Court issued to Gerbera Therapeutics, Inc. and Nanjing Noratech Pharmaceutical Co. Limited re [296] Redacted Document. Upon review it was determined this filing was not a complete version of what was filed at D.I. [287] . The redaction lacked Exhibit I. Defendants are to file a revised redacted version of D.I. [287] no later than three (3) days from the date of this notice. (nms) (Entered: 09/16/2024) DEFICIENCY NOTICE by the Court issued to Gerbera Therapeutics, Inc. and Nanjing Noratech Pharmaceutical Co. Limited re [296] Redacted Document. Upon review it was determined this filing was not a complete version of what was filed at D.I. [287] . The redaction lacked Exhibit I. Defendants are to file a revised redacted version of D.I. [287] no later than three (3) days from the date of this notice. (nms) (Entered: 09/16/2024)
09/16/24	Harmony Biosciences LLC v. Lupin Ltd 1:23-CV-01286 ( D. DE )	Pro Hac Vice Attorney Noorossadat Torabi for Biophore India Pharmaceuticals Private Limited and Zenara Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mws) (Entered: 09/16/2024)
09/13/24	Astellas Pharma Inc v. Lupin Ltd 1:23-CV-00819 ( D. DE )	Pro Hac Vice Attorney Ashley Ross for Astellas Ireland Co., Ltd. Astellas Pharma Global Development, Inc. and Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mws) (Entered: 09/13/2024)